BIOCHEMICAL MARKERS OF BONE TURNOVER IN SERONEGATIVE SPONDYLARTHROPATHY - RELATIONSHIP TO DISEASE-ACTIVITY

Citation
Ag. Macdonald et al., BIOCHEMICAL MARKERS OF BONE TURNOVER IN SERONEGATIVE SPONDYLARTHROPATHY - RELATIONSHIP TO DISEASE-ACTIVITY, British journal of rheumatology, 36(1), 1997, pp. 50-53
Citations number
22
Categorie Soggetti
Rheumatology
ISSN journal
02637103
Volume
36
Issue
1
Year of publication
1997
Pages
50 - 53
Database
ISI
SICI code
0263-7103(1997)36:1<50:BMOBTI>2.0.ZU;2-F
Abstract
To investigate bone turnover in patients with seronegative spondylarth ropathy, a bone formation marker, type 1 procollagen carboxy-terminal propeptide (P1CP), and resorption markers, the pyridinium cross-links of collagen [urinary free (f) PYR and DPYR], were measured. The median f-PYR, f-DPYR and P1CP (+/- interquartile range) were 15.8 (6.00) nmo l/mmol creatinine, 3.8 (2.2) nmol/mmol creatinine and 101.5 (38) mu g/ l, respectively. There was a positive correlation between resorption m arkers and acute-phase reactants such as C-reactive protein (r = 0.4 f or PYR, r = 0.42 for DPYR, P < 0.05), and a negative correlation obser ved between P1CP and the erythrocyte sedimentation rate (r = -0.64, P < 0.05). In the subgroup of patients with an elevated CRP concentratio n, the concentration of PYR and DPYR was significantly increased (f-PY R 25.7 vs 15.8 and f-DPYR 6.6 vs 3.8, P < 0.01 for f-PYR, P < 0.05 for f-DPYR). This study suggests than an elevation in acute-phase respons e in patients with seronegative spondylarthropathy is associated with increased concentration of bone resorption markers with a tendency for reduction in bone formation markers. This may represent uncoupling of bone formation and resorption, leading to bone loss in such patients.